Additionally, compound selectivity was further demonstrated by correlating RNA-sequencing (RNA-seq) gene expression changes from shRNA-mediated YAP1 knockdown and YTP-75 treatment in the NCI-H2052 mesothelioma cell line (Extended Data Fig. 4a). This evidence concerns the gene YAP1 and mesothelioma.